- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Feb 22, 2022
Emerging Company Profile
TargED: targeting thrombotic disorders directly at clotting sites
Dutch start-up with about €40M in funding will advance fusion protein targeting von Willebrand factor for two indications
BioCentury | Nov 12, 2015
Product R&D
Probodies, anticancer
How CytomX's Probodies improve safety across immuno-oncology modalities
BioCentury | Jun 14, 2010
Product Development
Pancreatic potential
Pancreatic cancer at ASCO: New non-chemo approaches show improved survival
Items per page:
1 - 10 of 12